Pill-punching patents

Raymond C Rowe¹

¹Pharmaceutical and Analytical R&D, AstraZeneca, Alderley Park, Macclesfield, Cheshire, UK SK10 2NA. Ray.Rowe@astrazeneca.com

Drug Discovery Today

|December 25, 2003

Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Establishing and analyzing the design space in the development of direct compression formulations by gene expression programming.

International journal of pharmaceutics·2012

Same author

Novel approaches to neural and evolutionary computing in pharmaceutical formulation: challenges and new possibilities.

Future medicinal chemistry·2011

Same author

Modelling drug dissolution from controlled release products using genetic programming.

International journal of pharmaceutics·2007

Same author

Film/tablet adhesion, film thickness, internal stresses and bridging of the intagliations--a unified model with practical implications.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2006

Same author

Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2006

Same author

More songs o' science.

Drug discovery today·2005

Same journal

Validation of AI-enabled surrogate models in quantitative systems pharmacology: a practical, context-of-use-driven review.

Drug discovery today·2026

Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026

Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026

Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026

Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026

Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026

See all related articles

Related Experiment Videos

Pill-punching patents

Related Concept Videos

Establishing and analyzing the design space in the development of direct compression formulations by gene expression programming.

Novel approaches to neural and evolutionary computing in pharmaceutical formulation: challenges and new possibilities.

Modelling drug dissolution from controlled release products using genetic programming.

Film/tablet adhesion, film thickness, internal stresses and bridging of the intagliations--a unified model with practical implications.

Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation.

More songs o' science.

Validation of AI-enabled surrogate models in quantitative systems pharmacology: a practical, context-of-use-driven review.

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Organoid-AI platforms need integrated governance in drug discovery.

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

HDAC11 as a potential therapeutic target for Alzheimer's disease.

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Related Experiment Videos

Pill-punching patents

Related Concept Videos

Establishing and analyzing the design space in the development of direct compression formulations by gene expression programming.

Novel approaches to neural and evolutionary computing in pharmaceutical formulation: challenges and new possibilities.

Modelling drug dissolution from controlled release products using genetic programming.

Film/tablet adhesion, film thickness, internal stresses and bridging of the intagliations--a unified model with practical implications.

Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation.

More songs o' science.

Validation of AI-enabled surrogate models in quantitative systems pharmacology: a practical, context-of-use-driven review.

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Organoid-AI platforms need integrated governance in drug discovery.

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

HDAC11 as a potential therapeutic target for Alzheimer's disease.

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Related Experiment Videos

Pill-punching patents

Related Concept Videos

Related Articles

Establishing and analyzing the design space in the development of direct compression formulations by gene expression programming.

Novel approaches to neural and evolutionary computing in pharmaceutical formulation: challenges and new possibilities.

Modelling drug dissolution from controlled release products using genetic programming.

Film/tablet adhesion, film thickness, internal stresses and bridging of the intagliations--a unified model with practical implications.

Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation.

More songs o' science.

Validation of AI-enabled surrogate models in quantitative systems pharmacology: a practical, context-of-use-driven review.

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Organoid-AI platforms need integrated governance in drug discovery.

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

HDAC11 as a potential therapeutic target for Alzheimer's disease.

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Related Experiment Videos

Pill-punching patents

Related Concept Videos

Related Articles

Establishing and analyzing the design space in the development of direct compression formulations by gene expression programming.

Novel approaches to neural and evolutionary computing in pharmaceutical formulation: challenges and new possibilities.

Modelling drug dissolution from controlled release products using genetic programming.

Film/tablet adhesion, film thickness, internal stresses and bridging of the intagliations--a unified model with practical implications.

Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation.

More songs o' science.

Validation of AI-enabled surrogate models in quantitative systems pharmacology: a practical, context-of-use-driven review.

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Organoid-AI platforms need integrated governance in drug discovery.

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

HDAC11 as a potential therapeutic target for Alzheimer's disease.

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.